相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
Roelof Koster et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Dichotomous function of IL-33 in health and disease: From biology to clinical implications
Harald Braun et al.
BIOCHEMICAL PHARMACOLOGY (2018)
A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33
Liang Ding et al.
CARCINOGENESIS (2018)
IL-33/IL-31 Axis: A Potential Inflammatory Pathway
Eleonora Di Salvo et al.
MEDIATORS OF INFLAMMATION (2018)
Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis
Ma Liang et al.
MEDIATORS OF INFLAMMATION (2018)
Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33
Corinne Cayrol et al.
NATURE IMMUNOLOGY (2018)
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
Min Yang et al.
PLOS ONE (2018)
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2018)
Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner
Moritz F. Eissmann et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma
Huoying Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells
Jintong Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Hui Xuan Lim et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma
Jianfei Zhang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Donye Dominguez et al.
JOURNAL OF IMMUNOLOGY (2017)
IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis
Yu Zhang et al.
MOLECULAR CARCINOGENESIS (2017)
Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice
Holger Meinicke et al.
IMMUNOLOGY (2017)
Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33
Wataru Ariyoshi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
Abdulraouf Ramadan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer
Yujiang Fang et al.
MEDICAL ONCOLOGY (2017)
TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine
A. Pascual-Reguant et al.
MUCOSAL IMMUNOLOGY (2017)
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
Sandra M. Kallert et al.
NATURE COMMUNICATIONS (2017)
IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
Kailing Wang et al.
Oncotarget (2017)
Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis
Ya-Ling Hsu et al.
ONCOTARGET (2017)
TH17 Cell and epithelial Cell Crosstalk during inflammatory Bowel Disease and Carcinogenesis
Jan Kempski et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Marie-Helene Wasmer et al.
FRONTIERS IN IMMUNOLOGY (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
Valeria Lucarini et al.
ONCOIMMUNOLOGY (2017)
The paradox of Th17 cell functions in tumor immunity
Zahra Asadzadeh et al.
CELLULAR IMMUNOLOGY (2017)
Pathophysiology of IL-33 and IL-17 in allergic disorders
Rinkesh Kumar Gupta et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
IL-33-expanded human Vγ9Vδ2 T cells have anti-lymphoma effect in a mouse tumor model
Caroline Duault et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer
Yang Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
IL-33-matured dendritic cells promote Th17 cell responses via IL-1β and IL-6
Su-Ho Park et al.
CYTOKINE (2017)
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Min Fang et al.
CANCER RESEARCH (2017)
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
Charlotte O'Donnell et al.
BRITISH JOURNAL OF CANCER (2016)
TCRVγ9 γδ T Cell Response to IL-33: A CD4 T Cell-Dependent Mechanism
Caroline Duault et al.
JOURNAL OF IMMUNOLOGY (2016)
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Xiaoguang Tong et al.
MOLECULAR ONCOLOGY (2016)
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
Kirsten D. Mertz et al.
ONCOIMMUNOLOGY (2016)
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
Peng Xiao et al.
ONCOIMMUNOLOGY (2016)
IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo
Mario Vaccaro et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
IL-33 signaling fuels outgrowth and metastasis of human lung cancer
Chunhong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung
Isme M. de Kleer et al.
IMMUNITY (2016)
Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth
Juyang Kim et al.
JOURNAL OF IMMUNOLOGY (2016)
IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma
Zewei Wang et al.
TUMOR BIOLOGY (2016)
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
Yinghua Zhao et al.
NATURE COMMUNICATIONS (2016)
The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages
Yunlong Yang et al.
NATURE COMMUNICATIONS (2016)
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
Miho Akimoto et al.
NATURE COMMUNICATIONS (2016)
Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma
Milos Z. Milosavljevic et al.
ONCOTARGET (2016)
Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
Lei Qin et al.
ONCOTARGET (2016)
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth
Alice Rigoni et al.
CANCER RESEARCH (2015)
IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway
Xi-Xiang Yu et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
IL-33 isoforms: their future as vaccine adjuvants?
Daniel O. Villarreal et al.
EXPERT REVIEW OF VACCINES (2015)
Tumor-infiltrating, interleukin-33-producing effector-memory CD8+ T cells in resected hepatocellular carcinoma prolong patient survival
Stefan M. Brunner et al.
HEPATOLOGY (2015)
Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation
Ari B. Molofsky et al.
IMMUNITY (2015)
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
Lukas F. Mager et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance
Jonathan M. Han et al.
JOURNAL OF IMMUNOLOGY (2015)
Circulating IL-33 level is associated with the progression of lung cancer
Myung Shin Kim et al.
LUNG CANCER (2015)
The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury
Sachin P. Gadani et al.
NEURON (2015)
IL-33 activates tumor stroma to promote intestinal polyposis
Rebecca L. Maywald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
Claudia Baumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Wei-Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease
Jilu Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
Xin Gao et al.
JOURNAL OF IMMUNOLOGY (2015)
Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity
J. Y. Kim et al.
ONCOGENE (2015)
Targeting IL-33 in Autoimmunity and Inflammation
Theoharis C. Theoharides et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
IL-33/ST2 pathway contributes to metastasis of human colorectal
Xuejian Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
Daniel O. Villarreal et al.
CANCER RESEARCH (2014)
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
James A. Rickard et al.
CELL (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation
Jun Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
IL-17A Promotes the Exacerbation of IL-33-Induced Airway Hyperresponsiveness by Enhancing Neutrophilic Inflammation via CXCR2 Signaling in Mice
Nobuaki Mizutani et al.
JOURNAL OF IMMUNOLOGY (2014)
α-Galactosylceramide but Not Phenyl-Glycolipids Induced NKT Cell Anergy and IL-33-Mediated Myeloid-Derived Suppressor Cell Accumulation via Upregulation of egr2/3
Jing-Rong Huang et al.
JOURNAL OF IMMUNOLOGY (2014)
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Chris Schiering et al.
NATURE (2014)
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress
Sumaira Z. Hasnain et al.
NATURE MEDICINE (2014)
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
Kuan-Min Fang et al.
NEURO-ONCOLOGY (2014)
Significance of interleukin-33 and its relatec cytokines in patients with breast cancers
Jing Liu et al.
FRONTIERS IN IMMUNOLOGY (2014)
Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
Kun Gao et al.
CANCER LETTERS (2013)
IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation
Clare S. Hardman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden
Pietro Santulli et al.
HUMAN REPRODUCTION (2013)
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Tamar Mchedlidze et al.
IMMUNITY (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression
Andrea Malfettone et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Cancer-Related Inflammation
Juliana Candido et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
Su-Feng Chen et al.
JOURNAL OF PATHOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
Dominik Bergis et al.
TRANSLATIONAL ONCOLOGY (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Dominique Talabot-Ayer et al.
JOINT BONE SPINE (2012)
Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
Rahul Kakkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain
Melanie Pichery et al.
JOURNAL OF IMMUNOLOGY (2012)
Detection of Interleukin-33 in Serum and Carcinoma Tissue from Patients with Hepatocellular Carcinoma and its Clinical Implications
P. Zhang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
IL-33: A Novel Danger Signal System in Atopic Dermatitis
Ferda Cevikbas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
Weldy V. Bonilla et al.
SCIENCE (2012)
The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB Radiation
Scott Napier Byrne et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Serum Interleukin-33 Levels in Patients with Gastric Cancer
Pinghu Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Ivan Jovanovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
IL-33 induces skin inflammation with mast cell and neutrophil activation
Axel J. Hueber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Mast Cells as Sensors of Cell Injury through IL-33 Recognition
Mattias Enoksson et al.
JOURNAL OF IMMUNOLOGY (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity
Ya-Jen Chang et al.
NATURE IMMUNOLOGY (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
IL-33 family members and asthma - bridging innate and adaptive immune responses
Clare M. Lloyd
CURRENT OPINION IN IMMUNOLOGY (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
Tatjana Pecaric-Petkovic et al.
BLOOD (2009)
The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
Elvire Bourgeois et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
IL-33-activated dendritic cells induce an atypical TH2-type response
Matthew A. Rank et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer
Maya Gulubova et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-33 Enhances Lipopolysaccharide-Induced Inflammatory Cytokine Production from Mouse Macrophages by Regulating Lipopolysaccharide Receptor Complex
Quentin Espinassous et al.
JOURNAL OF IMMUNOLOGY (2009)
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Corinne Cayrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors-Insight into Heterotrimeric IL-1 Signaling Complexes
Andreas Lingel et al.
STRUCTURE (2009)
IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall et al.
INTERNATIONAL IMMUNOLOGY (2008)
IL-1β-driven ST2L express ion promotes maturation resistance in rapamycin-conditioned dendritic cells
Heth R. Turnquist et al.
JOURNAL OF IMMUNOLOGY (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
David Moulin et al.
CYTOKINE (2007)
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells
Shafaqat Ali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IL-10 controls ultraviolet-induced carcinogenesis in mice
Karin Loser et al.
JOURNAL OF IMMUNOLOGY (2007)
ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis
Shunji Tajima et al.
EXPERIMENTAL LUNG RESEARCH (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules
ES Baekkevold et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
分享论文
